Terms: = Sarcomas AND NFE2L2, ENSG00000116044, 4780, Q16236, NRF2 AND Prognosis
8 results:
1. Prognostic and predictive biomarkers in paediatric solid tumours.
Glembocki AI; Somers GR
Pathology; 2024 Mar; 56(2):283-296. PubMed ID: 38216399
[TBL] [Abstract] [Full Text] [Related]
2. A risk score model based on endoplasmic reticulum stress related genes for predicting prognostic value of osteosarcoma.
Zhao Y; Gao J; Fan Y; Xu H; Wang Y; Yao P
BMC Musculoskelet Disord; 2023 Jun; 24(1):519. PubMed ID: 37353812
[TBL] [Abstract] [Full Text] [Related]
3. DDRGK1 Enhances Osteosarcoma Chemoresistance via Inhibiting KEAP1-Mediated nrf2 Ubiquitination.
Wang X; Zhou T; Yang X; Cao X; Jin G; Zhang P; Guo J; Rong K; Li B; Hu Y; Liu K; Ma P; Qin A; Zhao J
Adv Sci (Weinh); 2023 May; 10(14):e2204438. PubMed ID: 36965071
[TBL] [Abstract] [Full Text] [Related]
4. Autophagy inhibition and reactive oxygen species elimination by acetyl-CoA acetyltransferase 1 through fused in sarcoma protein to promote prostate cancer.
Guan J; Jiang X; Guo Y; Zhao W; Li J; Li Y; Cheng M; Fu L; Zhao Y; Li Q
BMC Cancer; 2022 Dec; 22(1):1313. PubMed ID: 36517760
[TBL] [Abstract] [Full Text] [Related]
5. TRIM22 inhibits osteosarcoma progression through destabilizing nrf2 and thus activation of ROS/AMPK/mTOR/autophagy signaling.
Liu W; Zhao Y; Wang G; Feng S; Ge X; Ye W; Wang Z; Zhu Y; Cai W; Bai J; Zhou X
Redox Biol; 2022 Jul; 53():102344. PubMed ID: 35636015
[TBL] [Abstract] [Full Text] [Related]
6. Pan-Cancer Multiomics Analysis of TC2N Gene Suggests its Important Role(s) in Tumourigenesis of Many Cancers.
Qureshi MA; Khan S; Tauheed MS; Syed SA; Ujjan ID; Lail A; Sharafat S
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3199-3209. PubMed ID: 33247676
[TBL] [Abstract] [Full Text] [Related]
7. Expression of the nrf2 and Keap1 proteins and their clinical significance in osteosarcoma.
Zhang J; Wang X; Wu W; Dang H; Wang B
Biochem Biophys Res Commun; 2016 Apr; 473(1):42-46. PubMed ID: 26987716
[TBL] [Abstract] [Full Text] [Related]
8. nrf2 expression is associated with poor outcome in osteosarcoma.
Park JY; Kim YW; Park YK
Pathology; 2012 Dec; 44(7):617-21. PubMed ID: 23172081
[TBL] [Abstract] [Full Text] [Related]
